In March 2025, the company declared new plans for any direct-to-buyer featuring of its Wegovy weight loss drug. The company set up a new pharmacy, known as NovoCare, which would charge customers $499 per month for usage of the drug, below 50 percent the cost of the drug via other pharmaceutical distribution networks.[fifty three]Include these bits